FDA Adverse Event Injury Summary report: N

HYDRUS MICROSTENT

MDR report key: 24326449 · Received February 12, 2026

Report

Report Number
3016075957-2026-00012
Event Type
Injury
Date Received
February 12, 2026
Report Date
May 6, 2026
Manufacturer
IVANTIS INC
Product Code
OGO
PMA / PMN Number
P170034
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. TRUBNIK V, HUANG L, HALL B. RETROSPECTIVE STUDY OF TWO-YEAR CLINICAL OUTCOMES OF COMBINATION AB-INTERNO CANALOPLASTY AND A MICROSTENT COMPARED TO AB-INTERNO CANALOPLASTY IN CATARACT SURGERY PATIENTS. CLIN OPHTHALMOL. 2025; 19:1991¿1997. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A HEALTHCARE PROFESSIONAL REPORTED VIA LITERATURE ARTICLE TO EVALUATE RETROSPECTIVE STUDY OF TWO YEAR CLINICAL OUTCOMES OF COMBINATION AB INTERNO CANALOPLASTY AND A MICROSTENT COMPARED TO AB INTERNO CANALOPLASTY IN CATARACT SURGERY PATIENTS. THIS FILE IS ABOUT PATIENT REQUIRED SECONDARY SURGICAL INTERVENTION. THERE ARE THREE MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS REPORT. THIS IS 3 OF 3. TRUBNIK V, HUANG L, HALL B. RETROSPECTIVE STUDY OF TWO-YEAR CLINICAL OUTCOMES OF COMBINATION AB-INTERNO CANALOPLASTY AND A MICROSTENT COMPARED TO AB-INTERNO CANALOPLASTY IN CATARACT SURGERY PATIENTS. CLIN OPHTHALMOL. 2025; 19:1991¿1997.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
142603 HYDRUS MICROSTENT INTRAOCULAR PRESSURE LOWERING IMPLANT OGO IVANTIS INC NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention